Very promising if the research can be replicated:
But how effective is the drug? This week, researcher Didier Raoult from Aix-Marseille University in France, one of the main proponents for using hydroxychloroquine to treat infection with the novel coronavirus—known as SARS-CoV-2—released encouraging results of a preliminary trial involving a total of 36 COVID-19 patients.
According to a draft paper—which has not yet been accepted for publication in a peer-reviewed scientific journal—six of these patients were asymptomatic, 22 had upper respiratory tract infection symptoms and eight had lower respiratory tract infection symptoms.
Between early and mid-March, Raoult and his team treated 20 of these patients with 600 milligrams of hydroxychloroquine daily in a hospital setting. Depending on their symptoms, an antibiotic known as azithromycin was also added to the treatments. This antibiotic is known to be effective against complications from bacterial lung disease. The 16 remaining patients were not given the drug as a control.
In the study, the scientists observed a "significant" reduction in viral load in the patients treated with hydroxychloroquine, and that the effect was reinforced by azithromycin, Medscape reported.
In fact, after six days, 70 percent of the treated patients were considered cured, meaning that the virus was no longer detected in samples taken from them, compared to 12.5 percent of the control group patients. Furthermore, all six patients who were treated with both hydroxychloroquine and the antibiotic azithromycin tested negative for the virus after six days.
While encouraging, it is important to note that this is an unpublished preliminary study, so the results should be viewed with caution. The sample size is small, and the study was non-randomized, meaning people were allocated to different interventions using non-random methods. The study was also "unblinded," meaning that all parties—i.e. the medical staff, patients and researchers—were aware of the treatments the participants received.
Donald Trump Says Malaria Drug for Coronavirus Has Been Approved by FDA
Okay good, everyone get back to work. I’m sick of California shutting down the economy to beg for money from the union.Very promising if the research can be replicated:
But how effective is the drug? This week, researcher Didier Raoult from Aix-Marseille University in France, one of the main proponents for using hydroxychloroquine to treat infection with the novel coronavirus—known as SARS-CoV-2—released encouraging results of a preliminary trial involving a total of 36 COVID-19 patients.
According to a draft paper—which has not yet been accepted for publication in a peer-reviewed scientific journal—six of these patients were asymptomatic, 22 had upper respiratory tract infection symptoms and eight had lower respiratory tract infection symptoms.
Between early and mid-March, Raoult and his team treated 20 of these patients with 600 milligrams of hydroxychloroquine daily in a hospital setting. Depending on their symptoms, an antibiotic known as azithromycin was also added to the treatments. This antibiotic is known to be effective against complications from bacterial lung disease. The 16 remaining patients were not given the drug as a control.
In the study, the scientists observed a "significant" reduction in viral load in the patients treated with hydroxychloroquine, and that the effect was reinforced by azithromycin, Medscape reported.
In fact, after six days, 70 percent of the treated patients were considered cured, meaning that the virus was no longer detected in samples taken from them, compared to 12.5 percent of the control group patients. Furthermore, all six patients who were treated with both hydroxychloroquine and the antibiotic azithromycin tested negative for the virus after six days.
While encouraging, it is important to note that this is an unpublished preliminary study, so the results should be viewed with caution. The sample size is small, and the study was non-randomized, meaning people were allocated to different interventions using non-random methods. The study was also "unblinded," meaning that all parties—i.e. the medical staff, patients and researchers—were aware of the treatments the participants received.
Donald Trump Says Malaria Drug for Coronavirus Has Been Approved by FDA
Without California and NYC the rest of the country would be third world.Okay good, everyone get back to work. I’m sick of California shutting down the economy to beg for money from the union.
I have always supported real science.Wait a minute. Science isn't real. Why are you advocating for "science" now?
So that's where your false sense of superiority originates.Without California and NYC the rest of the country would be third world.
For now, but the writing is on the wall for both of those states.Without California and NYC the rest of the country would be third world.
Both Cali and NYC have seen their fair share of disasters and we still here. We just get stronger.For now, but the writing is on the wall for both of those states.
We have several drivers pushing back their retirements due to their 401ks crashing
We have several drivers pushing back their retirements due to their 401ks crashing
Without California and NYC the rest of the country would be third world.
Renaming thread to Chinese Virus and infractioning everyone here participating.